SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BRADBURY DANIEL

(Last)

(First)

(Middle)

9360 TOWNE CENTRE DR

(Street)

SAN DIEGO

92121

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AMYLIN PHARMACEUTICALS INC [ AMLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)	X	Other (specify below)
	President & Chief Executive Of		President & Chief Executive Of

3. Date of Earliest Transaction (Month/Day/Year)
07/26/2012

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/26/2012		M		27,582	A	$11.95	113,779.2	D
Common Stock	07/26/2012		F		10,703⁽¹⁾	D	$30.795	103,076.2	D
Common Stock	07/26/2012		F		7,879⁽²⁾	D	$30.795	95,197.2	D
Common Stock	07/26/2012		M		8,418	A	$11.95	103,615.2	D
Common Stock	07/26/2012		F		3,266⁽¹⁾	D	$30.795	100,349.2	D
Common Stock	07/26/2012		F		2,404⁽²⁾	D	$30.795	97,945.2	D
Common Stock								42,897	I	By GRAT
Common Stock								13,456	I	Indirect-401k
Common Stock								7,974.4	I	by ESOP
Common Stock								36,931	I	by Trust⁽³⁾
Common Stock								23,923	I	by Trust-1⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Incentive Stock Option (right to buy)	$11.95	07/26/2012		M			8,418	⁽⁵⁾	08/02/2012	Common Stock	8,418	$0.0	0.0	D
Non-Qualified Stock Option (right to buy)	$11.95	07/26/2012		M			27,582	⁽⁵⁾	08/02/2012	Common Stock	27,582	$0.0	0.0	D

Explanation of Responses:

1. Represents the number of shares delivered to the Company to pay the exercise price of the option.

2. Represents the number of shares delivered to the Company for payment of tax withholding obligations incident to the exercise of stock options.

3. Includes 3,648 shares previously held by the reporting person's grantor annuity trust.

4. Shares held by the Bradbury Gift Trust, of which the reporting person's minor children are beneficiaries.

5. 25% of shares vest one year from the date of grant and the remainder vest monthly over the next three years becoming fully vested four years from the date of grant.

	By: /s/ James R. Oehler, Attorney-in-Fact For: Daniel M. Bradbury	07/26/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.